Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCA vs Salicylic Acid Peels for Rosacea
NCT04889703Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
01
Overview
Randomised, open-label trial of trichloroacetic acid and salicylic acid ointment in rosacea, sponsored by UT Southwestern Medical Center. Primary endpoint: Investigator Global Assessment at 12 weeks. Planned start Dec 2022; status: withdrawn.
02
Drugs
trichloroacetic acidsalicylic acid ointment
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT04889703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04889703.